Meeting
2013 Gastrointestinal Cancers Symposium
Neoadjuvant DCF in resectable esophageal cancer: Single-center experience.
Authors
Vanita Noronha
Tata Memorial Hospital
Vanita Noronha , Seema Gulia , Amit Joshi , Kumar Prabhash
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 31, 2013 (suppl 4; abstr124)
DOI
10.1200/jco.2013.31.4_suppl.124
Abstract #
124
Poster Bd #
C12
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy (TPF regimen) followed with robotic surgery and its impact on outcome in management of esophageal cancers: Indian experience.
First Author: S.P. Somashekhar
Poster
2015 Gastrointestinal Cancers Symposium
Evaluation of α-1-acid glycoprotein as a prognostic factor of survival in patients with stage II-III esophageal carcinoma treated with neoadjuvant docetaxel, cisplatin, and fluorouracil chemotherapy followed by surgery.
First Author: Yusuke Sasaki
Poster
2015 Gastrointestinal Cancers Symposium
Paclitaxel, carboplatin, and capecitabine (TCX) with and without radiation in locally advanced and metastatic distal esophageal and esophagogastric junction cancer: A single-center retrospective review.
First Author: Peter Joel Hosein
Poster
2013 ASCO Annual Meeting
A comparative study of the response and toxicities in locally advanced head and neck cancer patients treated with paclitaxel, cisplatinum, 5-FU versus docetaxel, cisplatinum, 5-FU as neoadjuvant chemotherapy followed by concurrent chemoradiation.
First Author: Diptirani Samanta